Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Envista | NVST | Nov 27, 2024 | 22.33 | +1.50 |
Envoy Medical A | COCH | Nov 27, 2024 | 2.29 | +3.62 |
enVVeno Medical | NVNO | Nov 27, 2024 | 3.19 | -0.62 |
Enzo Biochem | ENZ | Nov 27, 2024 | 1.03 | -0.96 |
EOG Resources | EOG | Nov 27, 2024 | 133.09 | +0.42 |
EON Resources A | EONR | Nov 27, 2024 | 0.75 | 0.00 |
Eos Energy Enterprises | EOSE | Nov 27, 2024 | 2.70 | +0.75 |
EPAM Systems | EPAM | Nov 27, 2024 | 245.79 | -1.16 |
EpicQuest Eduaction Group | EEIQ | Nov 27, 2024 | 1.03 | -0.23 |
ePlus | PLUS | Nov 27, 2024 | 80.81 | -2.29 |
EPR Properties | EPR | Nov 27, 2024 | 45.78 | +1.17 |
EPR Properties Pref C | EPR-C | Nov 27, 2024 | 21.31 | +0.05 |
EPR Properties Pref E | EPR-E | Nov 27, 2024 | 29.04 | -0.65 |
EPR Properties Pref G | EPR-G | Nov 27, 2024 | 22.08 | -0.36 |
Epsilon Energy | EPSN | Nov 27, 2024 | 5.78 | +0.17 |
EQT | EQT | Nov 27, 2024 | 45.28 | -0.61 |
Equifax | EFX | Nov 27, 2024 | 261.19 | +0.87 |
Equillium | EQ | Nov 27, 2024 | 0.77 | -1.27 |
Equinix | EQIX | Nov 27, 2024 | 979.10 | +0.09 |
Equinor ADR | EQNR | Nov 27, 2024 | 24.37 | +1.97 |
Equinox Gold | EQX | Nov 27, 2024 | 5.60 | +2.56 |
Equitable A Pref | EQH-A | Nov 27, 2024 | 22.32 | +0.22 |
Equitable C Pref | EQH-C | Nov 27, 2024 | 18.98 | +0.42 |
Equitable Holdings | EQH | Nov 27, 2024 | 48.08 | -0.48 |
Equity Bancshares A | EQBK | Nov 27, 2024 | 48.26 | -0.43 |
Equity Commonwealth | EQC | Nov 27, 2024 | 20.25 | +0.40 |
Equity Commonwealth D Pref | EQC-D | Nov 27, 2024 | 25.04 | +0.04 |
Equity Income Wisdomtree | DHS | Nov 27, 2024 | 100.48 | -0.01 |
Equity Lifestyle Properties | ELS | Nov 27, 2024 | 72.09 | +1.01 |
Equity Residential | EQR | Nov 27, 2024 | 77.48 | +0.49 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.